top of page

                                                                                                                                                                                      FOR IMMEDIATE RELEASE : 10-12-2020

Epigentor Consultants Inc.                                                        

Anindya Dutta M.D., Ph.D.,  Joins Epigentor Consultants Inc. as      Chief Science Officer     


Epigentor Consultants Inc. is pleased to welcome Dr. Anindya Dutta as Chief Science Officer. Dr. Dutta has contributed immensely to the scientific community throughout his distinguished career.  Epigentor will expand its core capabilities and key initiatives with Dr. Dutta's leadership and expertise. 

Dr. Dutta is a leader in the the study of mammalian cancer cell DNA replication initiation and mechanisms of genomic instability. His extremely impressive achievements include nearly two-hundred publications,  prestigious awards such as Outstanding Investigator Award (American Society of Investigative Pathology), Distinguished Scientist Award (University of Virginia), Mark Brothers Award (Indiana University), Ranbaxy Award, and being elected a Fellow of the American Association of Advancement of Science. Dr. Dutta has also served on the faculty of Harvard Medical School, at the University of Virginia School of Medicine , and edited for the Journals of Biological Chemistry and Cancer Research. 

Epigentor Consultants Inc. welcomes Dr. Dutta!

                                                                                                                                                                                      FOR IMMEDIATE RELEASE : 7-13-2020

Epigentor Consultants Inc.                                                        

Partnership with Sandia National Laboratories  

Epigentor Consultants Inc. is proud to announce a Cooperative Research and Development Agreement (CRADA) with Sandia Labs and Dr. Rempe, creator of the Memzyme™, from University of New Mexico. Epigentor is leveraging its own proprietary in-silico biological modeling platform to create bioremediation enzymes to complement and enhance the existing Memzyme™ technology for the active, efficient, and eco-friendly capture of CO2. This work is being funded in part by the  United States Department of Energy.


We are currently developing technology for the active conversion of CO2 into eco-friendly food and fuel sources. We are open to partnership and collaborative opportunities. If you are interested in partnering, please contact us at:

Watch the Memzyme™ in action below.


bottom of page